Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
154
days
Real-world rates and sites of recurrence after neoadjuvant chemoimmunotherapy in early-stage triple-negative breast cancer
Authors
Lauren M. Perry; Marisa Lazarus; Varadan Sevilimedu; Nicholas Mai; Giacomo Montagna; Hanna Kissane; Nour Abuhadra; Ellen Yang; Rachel Han; Hannah Y. Wen; Lior Braunstein; Monica Morrow; George Plitas; Stephanie Downs-CannerShow moreShow less
Affiliations
1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA; 2. Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA; 3. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 4. Breast Pathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 5. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USAShow moreShow less
104
days
Directional mitochondrial transfer and microenvironmental adaptation in breast cancer
Authors
Ke Xu; Zehao Wang; Jiong Wu; Jingyan XueShow moreShow less
Affiliations
1. Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaShow moreShow less
114
days
Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics
Authors
Sarah C. Van Alsten; Alyssa J. Cozzo; Qichen Wang; Andrew E. Walker; Erin L. Kirk; Xiaohua Gao; J. S. Marron; Melissa A. Troester; Katherine A. HoadleyShow moreShow less
Affiliations
1. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA; 2. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA; 3. Department of Statistics and Operations Research, University of North Carolina at Chapel Hill, Chapel Hill, USA; 4. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA; 5. Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA; 6. Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USAShow moreShow less
184
days
Nucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
Authors
Zsofia Sztupinszki; Judit Börcsök; Miklos Diossy; Aurel Prosz; Erica Mayer; Heather A. Parsons; Erica Stringer-Reasor; Vandana G. Abramson; Shannon L. Huggins-Puhalla; Daniel P. Silver; Antonio C. Wolff; Kent W. Mouw; Andrea L. Richardson; Zoltan SzallasiShow moreShow less
Affiliations
1. Computational Health Informatics Program, Boston Children’s Hospital, Harvard Medical School, Boston, USA; 2. Danish Cancer Institute, Copenhagen, Denmark; 3. Breast Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; 4. Fred Hutchinson Cancer Center, Seattle, USA; 5. Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, USA; 6. O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA; 7. Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, USA; 8. UPMC Hillman Cancer Center, Pittsburgh, USA; 9. Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA; 10. Johns Hopkins Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA; 11. Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; 12. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA; 13. Department of Bioinformatics, Semmelweis University, Budapest, HungaryShow moreShow less
159
days
Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1 - and BRCA2 -associated breast and ovarian cancer
Authors
Aishwarya Sekar; Julian Broche; Veronika Bursic; André Koch; Miguel Camarena Sainz; Jakob Admard; Andreas D. Hartkopf; Ines Gruber; Kristin Bosse; Stephan Ossowski; Christopher SchroederShow moreShow less
Affiliations
1. Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany; 2. Research Institute for Women’s Health, University of Tübingen, Tübingen, Germany; 3. Department of Women’s Health, University Hospital Tübingen, Tübingen, Germany; 4. Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, GermanyShow moreShow less
213
days
Matched ER+/ER − breast cancer models reveal disparate estrogen effects in mammary and pulmonary premetastatic environments
Authors
Kathleen A. O’Leary; Fern E. Murdoch; Hongtae Park; Brian M. Burkel; Suzanne M. Ponik; Lisa M. Arendt; Marulasiddappa Suresh; Linda A. SchulerShow moreShow less
Affiliations
1. Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, USA; 2. Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, USA; 3. Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA; 4. University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, USAShow moreShow less
FAQ
How long does npj Breast Cancer take to review a manuscript?
As of 2026-11-18, CrushSCI has 20 complete review records for npj Breast Cancer. The fastest paper went from submission to acceptance in 46 days (Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factors, received 2026-05-06, accepted 2026-06-21); the slowest took 309 days. The average is 146.4 days and the median is 135 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
